Watch the complete interview with embattled Mylan CEO Bresch

In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.